Medicare Outpatient Coverage Of Natrecor Could Be Limited To Clinical Trials

The Centers for Medicare & Medicaid Services' national coverage determination for Johnson & Johnson's Natrecor (nesiritide) will be one of the first opportunities for the agency to implement its "coverage with evidence development" policy